Royce & Associates’s Covanta Holding Corporation CVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-848,189
Closed -$14.9M 1038
2021
Q2
$14.9M Buy
848,189
+19,510
+2% +$297K 0.1% 334
2021
Q1
$11.5M Buy
828,679
+99,500
+14% +$1.42M 0.08% 404
2020
Q4
$9.57M Buy
729,179
+84,000
+13% +$909K 0.08% 381
2020
Q3
$5M Buy
645,179
+234,179
+57% +$2.15M 0.05% 475
2020
Q2
$3.94M Buy
411,000
+207,500
+102% +$1.77M 0.04% 506
2020
Q1
$1.74M Buy
+203,500
New +$2.74M 0.02% 629
2013
Q3
Sell
-9,200
Closed -$184K 1483
2013
Q2
$184K Buy
+9,200
New +$184K ﹤0.01% 1298

Other funds holding CVA

Royce & Associates's CVA Position: Q3 2021 in Review

Royce & Associates sold out of Covanta Holding Corporation (CVA) in Q3 2021, closing a stake of 848,189 shares — an estimated $14.9M sold.

Royce & Associates first reported a position in CVA in Q2 2013 and held it in 7 quarters. The position peaked at $14.9M in Q2 2021. 210 funds tracked by Wall St. Rank hold CVA as of Q3 2021.

  • Royce & Associates reported no remaining Covanta Holding Corporation position as of Q3 2021 after selling out during the quarter.
  • Royce & Associates sold 848,189 Covanta Holding Corporation shares in Q3 2021, an estimated $14.9M.
  • Royce & Associates first reported a position in Covanta Holding Corporation in Q2 2013 and held it in 7 quarters.
  • Royce & Associates's Covanta Holding Corporation position peaked at $14.9M in Q2 2021.
  • 210 funds tracked by Wall St. Rank held Covanta Holding Corporation as of Q3 2021.

Based on Royce & Associates's 13F filing for Q3 2021, filed 10 Nov 2021.